Artelo Biosciences (ARTL) Live Share Price, Invest From India

Artelo Biosciences Stock Performance

as on August 20, 2026 at 6:59 am IST

Day's Low
Day's High
$0.71
Day's Price Range
$0.75
$0.71
0.14%
Downside
5.49%
Upside
52 Week's Low
52 Week's High
$0.71
52-Week Price Range
$31.65
$0.71
0.83%
Downside
4351.48%
Upside

Artelo Biosciences share price movements today

Previous Close: $0.73
Open: $0.72
Volume: 379.7K
Market Cap: $2.8M
Day's Low - High: $0.71 - $0.75
52 Week Low - High: $0.71 - $31.65

Artelo Biosciences Historical Returns

1 Month Return: -31.29 %
3 Month Return: -57.05 %
1 Year Return: -97.37 %
3 Year Return: -97.78 %
5 Year Return: -99.64 %

Artelo Biosciences Stock Fundamentals & Key Indicators

Check Artelo Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.8M

EPS (TTM)

-9.84

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-7.4M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-367.70%

Artelo Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Artelo Biosciences with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Artelo Biosciences	BUY	$2.8M	-99.64%	NA	0.00%	NA
Revolution Medicines	BUY	$43.7B	669.3%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$128.2B	154.86%	29.82	86.04%	NA
Regeneron	BUY	$82.7B	24.1%	19.24	84.86%	0.44999999999999996%

Stock Returns calculator for Artelo Biosciences Stock including INR - Dollar returns

The Artelo Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Artelo Biosciences investment value today

Current value as on today

₹2,601

Returns

-₹97,399

(-97.4%)

Returns from Artelo Biosciences Stock

-₹97,635 (-97.63%)

Dollar Impact

₹236 (+0.24%)

Analyst Recommendation on Artelo Biosciences Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Artelo Biosciences. Average target price of $18

Artelo Biosciences Share Price Target

Get share price movements and forecasts by analysts on Artelo Biosciences.

What analysts predicted

96.05%UPSIDE

Target Price

$18

Current Price

$0.711

Analyzed by

9 Analysts

Target

$18.00

Artelo Biosciences target price $18, a slight upside of 96.05% compared to current price of $0.711. According to 9 analysts rating.

Indian Investors' Interest in Artelo Biosciences Stock

Search interest for Artelo Biosciences Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 21, 2026 to August 20, 2026

Change:-49% versus previous 30 day period

Artelo Biosciences Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-
Operating Income	-2	-2	-1	-3	-2	-3	-3	-2	-2
EBITDA	-2	-2	-1	-3	-2	-3	-3	-3	-2
Interest Expense	-	-	-	-	-	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-
Income Before Tax	-2	-2	-1	-3	-2	-3	-3	-4	-2
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-2	-2	-1	-3	-2	-3	-3	-4	-2
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Artelo Biosciences Annual Profit & Loss

All numbers in Millions USD

	Aug 2020	Dec 2020	Aug 2021	Dec 2021	Aug 2022	Dec 2022	Aug 2023	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-4	-	-7	-	-10	-	-9	-10	-11
EBITDA	-	-4	-	-7	-	-10	-	-9	-9	-12
Interest Expense	-	-	-	-	-	0	-	-	-	0
Depreciation	-	0	-	0	-	-	-	-	-	-
Income Before Tax	-	-4	-	-7	-	-10	-	-9	-9	-12
Income Tax Expense	-	0	-	0	-	0	-	-	-	-
Net Income	-4	-4	-7	-7	-10	-10	-9	-9	-9	-12
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Artelo Biosciences Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-2	-1	-3	-2	-3	-3	-4	-2	-2
Operating Cash Flow	-2	0	-2	-1	0	-3	-2	-1	-5
Investing Cash Flow	1	4	0	-	0	0	0	-	-
Financing Cash Flow	0	0	0	-	1	3	1	10	-1
Change in Cash	0	3	-2	-1	1	0	-1	9	-6

Artelo Biosciences Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-2	-2	-4	-7	-10	-9	-9	-12
Operating Cash Flow	-1	-2	-4	-6	-8	-8	-8	-8
Investing Cash Flow	0	-1	-3	-3	2	3	7	0
Financing Cash Flow	1	8	1	14	0	0	0	6
Change in Cash	0	4	-2	4	-5	-4	0	-1

Mutual Funds that own Artelo Biosciences Stock

Check out the Mutual Funds with significant holdings in Artelo Biosciences.

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	0.044125%	1538

Global Institutional Holdings in Artelo Biosciences

Funds	Holdings
Vanguard	0.29%

Insights on Artelo Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 491.1% return, outperforming this stock by 588.6%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 629.2% return, outperforming this stock by 727.1%
NEGATIVE IMPACT
Price Dip
In the last 1 month, ARTL stock has moved down by -36.5%

About Artelo Biosciences

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, and other potential indications. It also offers ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

Organisation	Artelo Biosciences
Headquarters	505 Lomas Santa Fe, Solana Beach, CA, United States, 92075
Industry	Biotechnology
CEO	Mr. Gregory D. Gorgas M.B.A.
E-voting on shares	Click here to vote

Key Management of Artelo Biosciences

Name	Title
Mr. Mark E. Spring CPA	CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer
Dr. Andrew Yates Ph.D.	Senior VP & Chief Scientific Officer
Dr. Steven D. Reich M.D.	Chief Medical Officer
Mr. Jason H. Baybutt	Senior Vice President of Finance
Mr. Gregory D. Gorgas M.B.A.	President, CEO, Secretary & Director

FAQs

What is Artelo Biosciences share price today?

Artelo Biosciences share price today is $0.71 as on August 20, 2026 at 1:29 am IST at the close of the market. Artelo Biosciences share today touched a day high of $0.75 and a low of $0.71.

What is the 52 week high and 52 week low for Artelo Biosciences share?

Artelo Biosciences share touched a 52 week high of $31.65 on August 18, 2025 and a 52 week low of $0.71 on August 10, 2026. Artelo Biosciences stock price today i.e. August 20, 2026 at 1:29 am IST is closed at $0.71,which is 97.75% down from its 52 week high and 0.84% up from its 52 week low.

What is Artelo Biosciences's market capitalisation today?

Artelo Biosciences market capitalisation is $0.00T as on August 20, 2026 at 1:29 am IST.

How to invest in Artelo Biosciences Stock (ARTL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Artelo Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Artelo Biosciences Shares that will get you 2.1097 shares as per Artelo Biosciences share price of $0.71 per share as on August 20, 2026 at 1:29 am IST.

What is the minimum amount required to buy Artelo Biosciences Stock (ARTL) from India?

Indian investors can start investing in Artelo Biosciences (ARTL) shares with as little as ₹95.743 or $1 (as of August 20, 2026 at 4:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.43 in Artelo Biosciences stock (as per the Rupee-Dollar exchange rate as on August 20, 2026 at 4:42 am IST). Based on Artelo Biosciences share’s latest price of $0.71 as on August 20, 2026 at 1:29 am IST, you will get 14.0647 shares of Artelo Biosciences. Learn more about fractional shares .

What are the returns that Artelo Biosciences has given to Indian investors in the last 5 years?

Artelo Biosciences stock has given -99.64% share price returns and 28.54% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?